NEW YORK (GenomeWeb News) — Ecopia BioSciences and Caprion Pharmaceuticals today said they received $45 million in a private placement tied to their merger.
The firms had said they expected to raise between $30 million and $45 million in the placement, which is being handled by the securities companies Desjardins and Dundee.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.